|
KIAA0247 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.659050E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.180100E-04 |
| Normal-vs-Stage2 |
3.163800E-01 |
| Normal-vs-Stage3 |
6.283800E-02 |
| Normal-vs-Stage4 |
5.590100E-02 |
| Stage1-vs-Stage2 |
2.708000E-01 |
| Stage1-vs-Stage3 |
2.523800E-01 |
| Stage1-vs-Stage4 |
3.493200E-01 |
| Stage2-vs-Stage3 |
7.794200E-01 |
| Stage2-vs-Stage4 |
7.128200E-01 |
| Stage3-vs-Stage4 |
8.725400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.966800E-04 |
| Normal-vs-AfricanAmerican |
1.218160E-02 |
| Normal-vs-Asian |
1.502370E-02 |
| Caucasian-vs-AfricanAmerican |
1.759030E-01 |
| Caucasian-vs-Asian |
5.217000E-01 |
| AfricanAmerican-vs-Asian |
5.149400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.683900E-02 |
| Normal-vs-Female |
7.816500E-04 |
| Male-vs-Female |
1.839960E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.179300E-04 |
| Normal-vs-Age(41-60Yrs) |
2.855500E-03 |
| Normal-vs-Age(61-80Yrs) |
5.921600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.945400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.185400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.084100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.421800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.585900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.126000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.197600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.508000E-02 |
| Classical-VS-Follicular |
2.62429966646494E-10 |
| Classical-VS-Other |
1.309000E-01 |
| Classical-VS-Normal |
1.17929999998712E-06 |
| Tall-VS-Follicular |
7.182900E-03 |
| Tall-VS-Other |
3.438800E-01 |
| Tall-VS-Normal |
8.123700E-02 |
| Follicular-VS-Other |
5.497800E-01 |
| Follicular-VS-Normal |
9.326500E-02 |
| Other-VS-Normal |
9.404200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.266590E-01 |
| Normal-vs-N1 |
1.361430E-01 |
| N0-vs-N1 |
6.759400E-01 |
|
|
